Disease is an equal opportunity inflector... It doesn't care what your politics are, it doesn't care if you are rich or poor, it doesn't care if you are black or white or Asian, it doesn't care if you are straight, gay, or trans.
When HIV was brought to America it could have been brought by a straight, married religious person, but it was brought here by a gay person and because of that the Republicans labeled it a gay disease by President Reagan!
The abrupt halt to US funding threatens to undo decades of advances, dramatically increasing infections and deaths, but some see an opportunity for Africa to lead the responseThe GuardianBy Kat LayMarch 18, 2025This year the world should have been “talking about the virtual elimination of HIV” in the near future. “Within five years,” says Prof Sharon Lewin, a leading researcher in the field. “Now that’s all very uncertain.”Scientific advances had allowed doctors and campaigners to feel optimistic that the end of HIV as a public health threat was just around the corner.Then came the Trump administration’s abrupt cuts to US aid funding. Now the picture is one of a return to the drugs rationing of decades ago, and of rising infections and deaths.But experts are also talking about building a new approach that would make health services, particularly those in sub-Saharan Africa, less vulnerable to the whims of a foreign power.The US has cancelled 83% of its foreign aid contracts and dismantled USAid, the agency responsible for coordinating most of them.
Let's face it it Trump is a bigot! He hates anything LGBTQ+.
He is also considering cutting domestic funding!
The cuts would seem to run counter to a first-term Trump priority.PoliticoBy Sophie GardnerMarch 18, 2025The Trump administration is discussing cuts to the CDC’s domestic HIV program, including funding for prevention, according to two former HHS officials who were granted anonymity to discuss their conversations with current staff.No decision has been made and an HHS official, who was granted anonymity to speak candidly, said that “if this decision is even made, this work would be continued elsewhere at HHS.”In a statement, HHS spokesperson Andrew Nixon told POLITICO that “HHS is following the Administration’s guidance and taking a careful look at all divisions to see where there is overlap that could be streamlined to support the President’s broader efforts to restructure the federal government.”Nixon said the aim “is to ensure that HHS better serves the American people at the highest and most efficient standard. No final decision on streamlining CDC’s HIV Prevention Division has been made.”
But wait! There's more!
The Kaiser Family Foundation (KFF) reports that,
Eliminating this funding could jeopardize recent successes in addressing the nation’s HIV epidemic, including those related to the Ending the HIV Epidemic (EHE) Initiative, which the first Trump administration created, and among other activities, bolstered HIV prevention efforts at the CDC by providing additional funding to a subset of targeted “EHE” jurisdictions. There has been a 12% decline in HIV incidence (new infections) nationally from 2018 to 2022 and a 21% decline in EHE jurisdictions between 2017 and 2022. CDC states that “increases in preexposure prophylaxis prescriptions, viral suppression, and HIV testing likely contributed to the decline,” activities that the agency has a core role in supporting.
He is also cutting research into new HIV drugs...
A groundbreaking injectable that would curb the spread of HIV is at risk due to Donald Trump's funding cuts on foreign aid.Black EnterpriseA groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to President Donald Trump’s recent executive orders.Lenacapavir, an innovative twice-yearly injection that prevents HIV transmission, was recognized as the breakthrough medicine of 2024. However, Trump’s decision to freeze all foreign aid funding now jeopardizes its global distribution to millions in need, Wired reports.Linda-Gail Bekker, 62, is a medical professor from the University of Cape Town who helped identify Lenacapavir. She attended the AIDS 2024 Conference held in Munich, Germany, last July and proudly presented the groundbreaking results of the PURPOSE 1 clinical trial she led. The study revealed that the Gilead Sciences-developed Lenacapavir could prevent sexual transmission of HIV with 100% efficacy by targeting the virus’s capsid protein, a crucial component for its replication.
Trump's loathing for anything LGBTQ+ is killing people!
No comments:
Post a Comment